PK Study of Oral Rivaroxaban in Healthy Subjects.

Trial Profile

PK Study of Oral Rivaroxaban in Healthy Subjects.

Phase of Trial: Phase I

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Thrombosis
  • Focus Pharmacokinetics
  • Sponsors Janssen
  • Most Recent Events

    • 01 Feb 2017 Last checked against record.
    • 29 Mar 2012 Actual patient number changed from 2 to 50 according to
    • 29 Mar 2012 Actual end date (December 2011) added as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top